hepatitis E
Information
- Disease name
- hepatitis E
- Disease ID
- DOID:4411
- Description
- "A viral infectious disease that results_in inflammation located_in liver, has_material_basis_in Hepatitis E virus, which is transmitted_by ingestion of contaminated food. The infection has_symptom fever, has_symptom fatigue, has_symptom loss of appetite, has_symptom nausea, has_symptom vomiting, has_symptom abdominal pain, has_symptom clay-colored bowel movements, has_symptom dark urine, has_symptom joint pain, and has_symptom jaundice." [url:http\://www.cdc.gov/hepatitis/HEV/HEVfaq.htm#section1]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT01014845 | Completed | Phase 3 | Clinical Trial of Recombinant Hepatitis E Vaccine | August 2007 | October 2017 |
| NCT02189603 | Completed | Phase 4 | Phase Ⅳ Clinical Trial of Recombinant Hepatitis E Vaccine（Hecolin®） | June 2014 | December 7, 2015 |
| NCT02190253 | Completed | Seroprevalence of Hepatitis E in People With an Organ Transplant | July 12, 2014 | February 5, 2019 | |
| NCT02417597 | Completed | Phase 4 | A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli) | April 2015 | May 2016 |
| NCT03282474 | Completed | Phase 2 | HepNet Pilot Trial: Multicenter Trial for the Treatment of Chronic Hepatitis E With Sofosbuvir (SofE) | December 7, 2017 | February 18, 2019 |
| NCT03365921 | Completed | Phase 4 | A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Lot Consistency Trial) | October 27, 2018 | June 16, 2019 |
| NCT03601221 | Completed | Seroprevalence Hepatitis E Infection in Healthy Blood Donors | May 29, 2018 | December 31, 2019 | |
| NCT03827395 | Completed | Phase 1 | Safety Study of Hepatitis E Vaccine (HEV239) | April 12, 2019 | August 28, 2020 |
| NCT04670419 | Completed | Morbidity and Mortality of Hepatitis E Virus Infections in Belgium | January 1, 2010 | December 31, 2018 | |
| NCT02584543 | Completed | Phase 4 | A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(Coadministration With Recombinant Hepatitis B Vaccine) | October 2015 | August 25, 2016 |
| NCT02603055 | Completed | Phase 1 | A Clinical Trial to Evaluate a Recombinant Hepatitis E Vaccine in Healthy Adults | July 2015 | August 2016 |
| NCT02847507 | Completed | Seroprevalence of Hepatitis E in HIV Positive Patients in Basque Country in 2016 (VIhVhEpb) | July 2016 | January 31, 2018 | |
| NCT02964910 | Completed | Phase 4 | A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Chronic Hepatitis B Patients ) | August 2016 | December 2017 |
| NCT03168412 | Completed | Phase 4 | A Study on the Recombinant Hepatitis E Vaccine (Escherichia Coli) (Accelerated Vaccination Schedule) | May 25, 2017 | November 28, 2018 |
| NCT05976594 | Recruiting | Long-term Effectiveness of a Recombinant Hepatitis E Vaccine | August 12, 2023 | July 1, 2025 | |
| NCT06137313 | Recruiting | Exposure to Hepatitis E Virus in Occitania, France | December 15, 2023 | November 14, 2024 | |
| NCT06457438 | Recruiting | N/A | Molecular Characteristics and Prevalence of Viral Hepatitis E in Human Tissue and Cell Donors | January 1, 2022 | December 2024 |
| NCT02558114 | Terminated | Phase 4 | Ribavirin for Severe Acute and Chronic Hepatitis E Virus Infection. | December 2015 | November 2018 |
| NCT03488589 | Unknown status | HEV in Patients With Acute Non-A, Non-B, Non-C Hepatitis in Al-Rajhy University Hospital for Liver | October 1, 2018 | October 1, 2020 |
- Disase is a (Disease Ontology)
- DOID:934
- Cross Reference ID (Disease Ontology)
- GARD:9541
- Cross Reference ID (Disease Ontology)
- MESH:D016751
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:7111000119109
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0085293
- MeSH unique ID (MeSH (Medical Subject Headings))
- D016751